Windlas Biotech Limited which had tapped the capital markets with its fresh issue of Rs 165 crs and an offer for sale of 51,42,067 equity shares in a price band of Rs 448-460, was subscribed 22.56 times.

Earlier the company had completed its allocation to anchor investors by allotting 26,18,706 equity shares at Rs 460 to 12 anchor investors comprising of 22 entities.

The highest allocation was made ICICI Prudential Pharma Healthcare Fund of 5,43,450 equity shares or 20.75% of the anchor allocation. This was followed by an equal allotment of 2,17,410 shares or 8.30% to 8 anchors. This implies that the top nine anchors were allotted 87.15% of the anchor portion.

The issue had opened on Wednesday the 4th of August and closed on Friday the 6th of August.

The QIB portion was subscribed 24.10 times, HNI portion was subscribed 15.91 times while Retail portion was subscribed 24.54 times. There were 21.01 lac applications and on basis of applications, the retail issue was subscribed 20.63 times.

Full details of the subscription are given below: –